Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity

Saborni Chakraborty(Stanford University), Taia T. Wang(Chan Zuckerberg Initiative (United States)), Paul J. Utz(Stanford University), Courtney Scallan(Stanford University), Elizabeth Mellins(Stanford University), Vamsee Mallajosyula(Stanford University), Mary Prahl(University of California, San Francisco), Steven T. Chen(Tisch Hospital), Mark M. Davis(Howard Hughes Medical Institute), Fei Gao(Stanford University), Prasanna Jagannathan(University of California, San Francisco), Nimish Kathale(Stanford University), Kari C. Nadeau(Stanford University), Aanika Sinnott(J. Craig Venter Institute), Chaitan Khosla(Stanford University), Bali Pulendran(Stanford University), Prabhu S. Arunachalam(Jawaharlal Nehru Centre for Advanced Scientific Research), Xuhuai Ji(Stanford University), Marisa Holubar(Stanford University), Terri Gelbart(J. Craig Venter Institute), Seunghee Kim‐Schulze(Icahn School of Medicine at Mount Sinai), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Joseph C. González(Stanford University), Upinder Singh(Stanford University), Scott D. Boyd(Stanford Medicine), Bowie Yik-Ling Cheng(Stanford University), Holden T. Maecker(Stanford University), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Yarden Golan(QB3), Sacha Gnjatic(Mount Sinai Hospital), Aruna Subramanian(Stanford University), Benjamín L. Sievers(J. Craig Venter Institute), Usama Ashraf(Stanford University), Arianna G. Cassidy(University of California, San Francisco), Robert Sherwood(Cornell University), Gene S. Tan(J. Craig Venter Institute), Megha Dubey(Central Drug Research Institute), Sheng Zhang(Capital Institute of Pediatrics), Stephanie L. Gaw(University of California, San Francisco), Srijoni Chakraborty(San Jose State University), Kim Q.T. Tran(Stanford University), Yvonne Maldonado(Stanford University)
Science Translational Medicine
January 18, 2022
Cited by 137


Related Papers